Surveillance of Pediatric Invasive Bacterial Diseases in the Veneto Region: Epidemiological Trends and Outcomes over 17 Years (2007–2023)
Abstract
:1. Introduction
2. Materials and Methods
2.1. Study Population and Data Source
2.2. Inclusion Criteria and Case Definition
2.3. Statistical Analysis
2.4. Ethics Statement
3. Results
3.1. Characterization of Pediatric IBD Cases
3.2. Trends in Notification and Case Fatality Rate
3.3. Evolution of Serotype Distribution
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Acknowledgments
Conflicts of Interest
Appendix A
Microorganism | Vaccination Evolution in the Veneto Region |
---|---|
N. meningitidis B | The meningococcal B (MenB) vaccine is administered in a three-dose schedule: the first dose at 76 days after birth, the second at 151 days after birth, and the third at 13 months of age. The MenB vaccine was first introduced in the Veneto Region for newborns of the 2015 cohort. A significant change was implemented in August 2023, as the region now offers the MenB vaccine to all adolescents and young adults born between 1997 and 2009. This updated vaccination strategy aims to address the rising number of meningococcal B cases among young people, observed since the resumption of normal social interactions post-pandemic. The vaccine is actively offered, with invitations extended to newly turned 14-year-olds [47]. |
N. meningitidis ACWY | Vaccination against meningococcal serogroups A, C, W, and Y (MenACWY) is recommended at one year of age, with a booster dose provided for adolescents at 13 years of age. The MenACWY vaccine replaced the MenC vaccine in the Veneto Region starting in 2015. Vaccination against serogroup C was initially introduced in Veneto Region in 2005 and was offered to newborns at 13 months of age. This vaccination was later extended to 15-year-old adolescents and, starting in 2008, to 6-year-old children in response to an increase in meningococcal disease cases caused by this strain [48]. |
S. pneumoniae | The routine schedule for the conjugate pneumococcal vaccine (PCV) provides the first dose at two months of age, the second dose at four months, and the final dose at ten months of age. The PCV for newborns was introduced in the Veneto Region in 2006. Previously, the 23-valent polysaccharide pneumococcal vaccine (PPSV23) was available, but it is now used only in sequential combination. Initially, in 2002, the conjugate vaccine covered seven serotypes (PCV7): 4, 6B, 9V, 14, 18C, 19F, and 23F. In 2010, it was expanded to PCV10, which added serotypes 1, 5, and 7F, and subsequently to PCV13 in 2014, which further included serotypes 3, 6A, and 19A. More recently, a 15-valent vaccine, which additionally covers serotypes 22F and 33F, was authorized by AIFA (Agenzia Italiana del Farmaco) in 2022. A 20-valent vaccine, which also includes serotypes 8, 10A, 11A, 12F, and 15B, was approved by the EMA (European Medicines Agency) in 2022. Additionally, a 21-valent vaccine, incorporating a new subset of serotypes (3, 6Aa, 7F, 8, 9N, 10A, 11A, 12F, 15A, 15Cab, 16F, 17F, 19A, 20, 22F, 23A, 23B, 24F, 31, 33F, and 35B), was licensed by the FDA (U.S. Food and Drug Administration) in 2024, though it is not yet available in Europe [49]. |
H. influenzae | Regarding H. influenzae, the routine schedule of the Hib vaccine (as part of the hexavalent vaccine) has consisted of three doses co-administered with pneumococcal vaccine since 2002. The vaccine against H. influenzae type b was introduced in the Veneto Region in 1999 as part of the pediatric vaccination program. Initially, it was administered as a monovalent vaccine or in combination with other vaccines. The Hib vaccine is mandatory based on Italian law [50]. |
References
- Song, S.H.; Lee, H.; Lee, H.J.; Song, E.S.; Ahn, J.G.; Park, S.E.; Lee, T.; Cho, H.-K.; Lee, J.; Kim, Y.-J.; et al. Twenty-Five Year Trend Change in the Etiology of Pediatric Invasive Bacterial Infections in Korea, 1996–2020. J. Korean Med. Sci. 2023, 38, e127. [Google Scholar] [CrossRef] [PubMed]
- WHO. Defeating Meningitis by 2030: Baseline Situation Analysis; WHO: Geneve, Switzerland, 2019.
- McIntyre, P.B.; O’Brien, K.L.; Greenwood, B.; van de Beek, D. Effect of Vaccines on Bacterial Meningitis Worldwide. Lancet 2012, 380, 1703–1711. [Google Scholar] [CrossRef]
- Tan, E.; Beck, S.; Haskell, L.; MacLean, A.; Rogan, A.; Than, M.; Venning, B.; White, C.; Yates, K.; McKinlay, C.J.; et al. Paediatric Fever Management Practices and Antipyretic Use among Doctors and Nurses in New Zealand Emergency Departments. Emerg. Med. Australas. 2022, 34, 943–953. [Google Scholar] [CrossRef]
- O’Brien, K.L.; Wolfson, L.J.; Watt, J.P.; Henkle, E.; Deloria-Knoll, M.; McCall, N.; Lee, E.; Mulholland, K.; Levine, O.S.; Cherian, T.; et al. Burden of Disease Caused by Streptococcus pneumoniae in Children Younger than 5 Years: Global Estimates. Lancet 2009, 374, 893–902. [Google Scholar] [CrossRef]
- Martinelli, D.; Fortunato, F.; Prato, R. Estimates of the Burden of Meningococcal Disease in Italy: Implications for Prevention and Control. J. Prev. Med. Hyg. 2015, 56, E112–E115. [Google Scholar]
- Loughran, A.J.; Orihuela, C.J.; Tuomanen, E.I. Streptococcus pneumoniae: Invasion and Inflammation. Microbiol. Spectr. 2019, 7, 10-1128. [Google Scholar] [CrossRef]
- Swain, C.L.; Martin, D.R. Survival of Meningococci Outside of the Host: Implications for Acquisition. Epidemiol. Infect. 2007, 135, 315–320. [Google Scholar] [CrossRef] [PubMed]
- Mukundan, D.; Ecevit, Z.; Patel, M.; Marrs, C.F.; Gilsdorf, J.R. Pharyngeal Colonization Dynamics of Haemophilus influenzae and Haemophilus haemolyticus in Healthy Adult Carriers. J. Clin. Microbiol. 2007, 45, 3207–3217. [Google Scholar] [CrossRef]
- European Centre for Disease Prevention and Control (ECDC). Invasive Pneumococcal Disease; Annual epidemiological report for 2018; ECDC: Stockholm, Sweden, 2020. [Google Scholar]
- European Centre for Disease Prevention and Control (ECDC). Haemophilus influenzae; Annual epidemiological report for 2018; ECDC: Stockholm, Sweden, 2020. [Google Scholar]
- European Centre for Disease Prevention and Control (ECDC). Haemophilus influenzae; Annual epidemiological report for 2021; ECDC: Stockholm, Sweden, 2024. [Google Scholar]
- European Centre for Disease Prevention and Control (ECDC). Invasive Meningococcal Disease; Annual epidemiological report for 2022; ECDC: Stockholm, Sweden, 2024. [Google Scholar]
- Lohrmann, F.; Hufnagel, M.; Kunze, M.; Afshar, B.; Creti, R.; Detcheva, A.; Kozakova, J.; Rodriguez-Granger, J.; Sørensen, U.B.S.; Margarit, I.; et al. Neonatal Invasive Disease Caused by Streptococcus agalactiae in Europe: The DEVANI Multi-Center Study. Infection 2023, 51, 981–991. [Google Scholar] [CrossRef] [PubMed]
- European Centre for Disease Prevention and Control (ECDC). Increase in Invasive Group A Streptococcal Infections among Children in Europe, Including Fatalities. Available online: https://www.ecdc.europa.eu/en/news-events/increase-invasive-group-streptococcal-infections-among-children-europe-including (accessed on 10 January 2025).
- Gaschignard, J.; Koehl, B.; Rees, D.C.; Rincón-López, E.; Vanderfaeillie, A.; Pascault, A.; Allali, S.; Cela, E.; Odièvre, M.-H.; Hau, I.; et al. Invasive Bacterial Infections in Children With Sickle Cell Disease: 2014–2019. Pediatrics 2023, 152, e2022061061. [Google Scholar] [CrossRef]
- Slack, M.P.E.; Cripps, A.W.; Grimwood, K.; Mackenzie, G.A.; Ulanova, M. Invasive Haemophilus influenzae Infections after 3 Decades of Hib Protein Conjugate Vaccine Use. Clin. Microbiol. Rev. 2021, 34, e0002821. [Google Scholar] [CrossRef]
- Ministero della Salute. Piano Nazionale Della Prevenzione Vaccinale 2023–2025 [National Vaccine Prevention Plan 2023–2025]. 2023. Available online: https://www.salute.gov.it/portale/vaccinazioni/dettaglioContenutiVaccinazioni.jsp?lingua=italiano&id=4828&area=vaccinazioni&menu=vuoto (accessed on 10 January 2025).
- Shaw, D.; Abad, R.; Amin-Chowdhury, Z.; Bautista, A.; Bennett, D.; Broughton, K.; Cao, B.; Casanova, C.; Choi, E.H.; Chu, Y.W.; et al. Trends in Invasive Bacterial Diseases during the First 2 Years of the COVID-19 Pandemic: Analyses of Prospective Surveillance Data from 30 Countries and Territories in the IRIS Consortium. Lancet Digit. Health 2023, 5, e582–e593. [Google Scholar] [CrossRef] [PubMed]
- Istat (Istituto Nazionale di Statistica). Demo—Statistiche Demografiche. Available online: https://demo.istat.it/?l=it (accessed on 18 June 2024).
- Istat (Istituto Nazionale di Statistica). Indicatori Demografici. Available online: https://demo.istat.it/tavole/?t=indicatori&l=it (accessed on 10 January 2025).
- Cocchio, S.; Cozzolino, C.; Cozza, A.; Furlan, P.; Amoruso, I.; Zanella, F.; Da Re, F.; Ballarin, D.; Pagin, G.; Gentili, D.; et al. Invasive Pneumococcal Diseases in People over 65 in Veneto Region Surveillance. Vaccines 2024, 12, 1202. [Google Scholar] [CrossRef]
- Ferre, F.; de Belvis, A.G.; Valerio, L.; Longhi, S.; Lazzari, A.; Fattore, G.; Ricciardi, W.; Maresso, A. Italy: Health System Review. Health Syst. Transit. 2014, 16, 1–168. [Google Scholar]
- Cocchio, S.; Cozzolino, C.; Furlan, P.; Cozza, A.; Tonon, M.; Russo, F.; Saia, M.; Baldo, V. Pneumonia-Related Hospitalizations among the Elderly: A Retrospective Study in Northeast Italy. Diseases 2024, 12, 254. [Google Scholar] [CrossRef]
- Regione del Veneto Sistema Informativo Regionale Malattie Infettive (SIRMI). Available online: https://apms.azero.veneto.it/idp/profile/SAML2/Redirect/SSO?execution=e2s1 (accessed on 10 January 2025).
- Baldovin, T.; Lazzari, R.; Russo, F.; Bertoncello, C.; Buja, A.; Furlan, P.; Cocchio, S.; Palù, G.; Baldo, V. A Surveillance System of Invasive Pneumococcal Disease in North-Eastern Italy. Ann. Ig. 2016, 28, 15–24. [Google Scholar] [CrossRef]
- European Centre for Disease Prevention and Control (ECDC). EU Case Definitions. Available online: https://www.ecdc.europa.eu/en/all-topics/eu-case-definitions (accessed on 16 September 2024).
- European Union. Commission Implementing Decision (EU) 2018/945 of 22 June 2018 on the Communicable Diseases and Related Special Health Issues to Be Covered by Epidemiological Surveillance as Well as Relevant Case Definitions. Off. J. Eur. Union 2018, 6, 1–74. [Google Scholar]
- Statistical Methodology and Applications Branch, Surveillance Research Program, National Cancer Institute Joinpoint Regression Program. Available online: https://surveillance.cancer.gov/joinpoint/ (accessed on 18 June 2024).
- Azzari, C.; Moriondo, M.; Di Pietro, P.; Di Bari, C.; Resti, M.; Mannelli, F.; Esposito, S.; Castelli-Gattinara, G.; Campa, A.; de Benedictis, F.M.; et al. The Burden of Bacteremia and Invasive Diseases in Children Aged Less than Five Years with Fever in Italy. Ital. J. Pediatr. 2015, 41, 92. [Google Scholar] [CrossRef]
- Phuong, L.K.; Cheung, A.; Agrawal, R.; Butters, C.; Buttery, J.; Clark, J.; Connell, T.; Curtis, N.; Daley, A.J.; Dobinson, H.C.; et al. Inborn Errors of Immunity in Children With Invasive Pneumococcal Disease: A Multicenter Prospective Study. Pediatr. Infect. Dis. J. 2023, 42, 908–913. [Google Scholar] [CrossRef]
- Howley, E.; Golwala, Z.; Buckland, M.; Barzaghi, F.; Ghosh, S.; Hackett, S.; Hague, R.; Hauck, F.; Holzer, U.; Klocperk, A.; et al. Impact of Newborn Screening for SCID on the Management of Congenital Athymia. J. Allergy Clin. Immunol. 2024, 153, 330–334. [Google Scholar] [CrossRef]
- Brueggemann, A.B.; Jansen van Rensburg, M.J.; Shaw, D.; McCarthy, N.D.; Jolley, K.A.; Maiden, M.C.J.; van der Linden, M.P.G.; Amin-Chowdhury, Z.; Bennett, D.E.; Borrow, R.; et al. Changes in the Incidence of Invasive Disease Due to Streptococcus pneumoniae, Haemophilus influenzae and Neisseria meningitidis during the COVID-19 Pandemic in 26 Countries and Territories in the Invasive Respiratory Infection Surveillance Initiative: A Prospective Analysis of Surveillance Data. Lancet Digit. Health 2021, 3, e360–e370. [Google Scholar] [CrossRef]
- Casanova, C.; Küffer, M.; Leib, S.L.; Hilty, M. Re-Emergence of Invasive Pneumococcal Disease (IPD) and Increase of Serotype 23B after Easing of COVID-19 Measures, Switzerland, 2021. Emerg. Microbes. Infect. 2021, 10, 2202–2204. [Google Scholar] [CrossRef] [PubMed]
- Steens, A.; Knol, M.J.; Freudenburg-de Graaf, W.; de Melker, H.E.; van der Ende, A.; van Sorge, N.M. Pathogen- and Type-Specific Changes in Invasive Bacterial Disease Epidemiology during the First Year of the COVID-19 Pandemic in The Netherlands. Microorganisms 2022, 10, 972. [Google Scholar] [CrossRef]
- Fazio, C.; Camilli, R.; Giufré, M.; Urciuoli, R.; Boros, S.; Neri, A.; Del Grosso, M.; Vacca, P.; Giancristofaro, S.; Siddu, A.; et al. Sorveglianza Nazionale Delle Malattie Batteriche Invasive. Dati 2021–2023; Rapporti ISS Sorveglianza RIS-2/2024; Istituto Superiore di Sanità (ISS): Rome, Italy, 2024. [Google Scholar]
- Barbiellini Amidei, C.; Buja, A.; Bardin, A.; Bonaldi, F.; Paganini, M.; Manfredi, M.; Favaro, A.; Baldo, V.; Saia, M.; Da Dalt, L. Pediatric Emergency Department Visits during the COVID-19 Pandemic: A Large Retrospective Population-Based Study. Ital. J. Pediatr. 2021, 47, 218. [Google Scholar] [CrossRef] [PubMed]
- Burckhardt, I.; Burckhardt, F. Epidemiology of Streptococcus pyogenes Disease before, during, and after COVID-19 Pandemic, Germany, 2005–2023. Emerg. Infect. Dis. 2024, 30, 2435–2438. [Google Scholar] [CrossRef]
- Guzzi, L.; Sambade, J.M.; Christin, M.D.; Rodriguez Cairoli, F.; Rodriguez, A.; Vicario, S.; Hinojosa Del Carpio, M.; Molinos, J.; Dimitroff, P. Reduction in the Incidence of Invasive Infections Caused by Encapsulated Bacteria after the Onset of the COVID-19 Pandemic. Rev. Argent. Microbiol. 2024, 56, 62–68. [Google Scholar] [CrossRef]
- Lindh, E.; Imperi, M.; Alfarone, G.; Pataracchia, M.; Recchia, S.; Creti, R. La Malattia Invasiva Neonatale Da Streptococco Di Gruppo B in Italia: Anni 2015–2018. Not. Ist. Super. Sanità 2020, 33, 14–18. [Google Scholar]
- Luck, J.N.; Tettelin, H.; Orihuela, C.J. Sugar-Coated Killer: Serotype 3 Pneumococcal Disease. Front. Cell Infect. Microbiol. 2020, 10, 613287. [Google Scholar] [CrossRef]
- Harrison, L.H.; Pelton, S.I.; Wilder-Smith, A.; Holst, J.; Safadi, M.A.P.; Vazquez, J.A.; Taha, M.-K.; LaForce, F.M.; von Gottberg, A.; Borrow, R.; et al. The Global Meningococcal Initiative: Recommendations for Reducing the Global Burden of Meningococcal Disease. Vaccine 2011, 29, 3363–3371. [Google Scholar] [CrossRef]
- Baldovin, T.; Lazzari, R.; Cocchio, S.; Furlan, P.; Bertoncello, C.; Saia, M.; Russo, F.; Baldo, V. Invasive Meningococcal Disease in the Veneto Region of Italy: A Capture-Recapture Analysis for Assessing the Effectiveness of an Integrated Surveillance System. BMJ Open 2017, 7, e012478. [Google Scholar] [CrossRef]
- Ministero della Salute Vaccinazioni dell’età Pediatrica e Dell’adolescenza—Coperture Vaccinali. Available online: https://www.salute.gov.it/portale/documentazione/p6_2_8_1_1.jsp?lingua=italiano&id=38 (accessed on 10 January 2025).
- Rosu, M.; Sacco, C.; Giufrè, P.; Pezzotti, P. National Surveillance System for Invasive Haemophilus influenzae Disease in Italy: Evaluation of Completeness and Timeliness, 2016–2022. In Proceedings of the European Scientific Conference on Applied Infectious Disease Epidemiology (ESCAIDE), Stockholm, Sweden, 20–22 November 2024; Available online: https://www.escaide.eu/sites/default/files/documents/ESCAIDE-2024-Abstract-book_0.pdf (accessed on 10 January 2025).
- Trotter, C.L.; McVernon, J.; Ramsay, M.E.; Whitney, C.G.; Mulholland, E.K.; Goldblatt, D.; Hombach, J.; Kieny, M.-P. SAGE subgroup Optimising the Use of Conjugate Vaccines to Prevent Disease Caused by Haemophilus influenzae Type b, Neisseria meningitidis and Streptococcus pneumoniae. Vaccine 2008, 26, 4434–4445. [Google Scholar] [CrossRef]
- Regione Del Veneto. Deliberazione Della Giunta Regionale n. 990 Del 11 Agosto 2023 Recepimento Dell’Intesa Della Conferenza Stato-Regioni Sul Documento Recante “Piano Nazionale Di Prevenzione Vaccinale (PNPV) 2023-2025” e Sul Documento Recante “Calendario Nazionale Vaccinale” (Rep. Atti n. 193/CSR Del 02/08/2023) e Rafforzamento Delle Strategie Di Prevenzione Vaccinale Con Contestuale Aggiornamento Dell’Offerta Della Regione Del Veneto. Allegato B. Available online: https://bur.regione.veneto.it/BurvServices/pubblica/DettaglioDgr.aspx?id=510195 (accessed on 10 January 2025).
- Regione Del Veneto. Deliberazione Della Giunta Regionale n. 1564 Del 26 Agosto 2014 Approvazione Nuovo “Calendario Vaccinale” Della Regione Del Veneto. Parziale Modifica Della D.G.R. n. 411 Del 26.02.2008, Approvazione Documento “Offerta Vaccinazioni Soggetti a Rischio”, Approvazione “Programma Di Formazione per Gli Operatori Sanitari”, Approvazione Documento “Piano Di Comunicazione a Sostegno Delle Malattie Infettive Prevenibili Con Vaccino”. Available online: https://bur.regione.veneto.it/BurvServices/pubblica/DettaglioDgr.aspx?id=281075 (accessed on 10 January 2025).
- Mullard, A. FDA Approves 21-Valent Pneumococcal Vaccine. Nat. Rev. Drug Discov. 2024, 23, 572. [Google Scholar] [CrossRef] [PubMed]
- Ministero della Salute Disposizioni Urgenti in Materia di Prevenzione Vaccinale (G.U. Serie Generale, n. 130 Del 07 Giugno 2017). Available online: https://www.trovanorme.salute.gov.it/norme/dettaglioAtto?id=59548 (accessed on 10 January 2025).
Variable | Age (Years) | Total | p-Value * | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
0 | 1–4 | 05-Set | 10–14 | 15+ | 0–17 | |||||||||||||||
n | c % | r % | n | c % | r % | n | c % | r % | n | c % | r % | n | c % | r % | n | c % | r % | |||
Etiological agent | Streptococcus pneumoniae | 77 | 38.7 | 26.4 | 119 | 65.4 | 40.8 | 70 | 76.9 | 24.0 | 15 | 51.7 | 5.1 | 11 | 32.4 | 3.8 | 292 | 54.6 | 100 | <0.001 |
Neisseria meningitidis | 29 | 14.6 | 27.6 | 39 | 21.4 | 37.1 | 8 | 8.8 | 7.6 | 9 | 31.0 | 8.6 | 20 | 58.8 | 19.0 | 105 | 19.6 | 100 | ||
Streptococcus agalactiae | 70 | 35.2 | 97.2 | 0 | 0.0 | 0.0 | 2 | 2.2 | 2.8 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 72 | 13.5 | 100 | ||
Haemophilus influenzae | 17 | 8.5 | 41.5 | 13 | 7.1 | 31.7 | 7 | 7.7 | 17.1 | 3 | 10.3 | 7.3 | 1 | 2.9 | 2.4 | 41 | 7.7 | 100 | ||
Streptococcus pyogenes | 6 | 3.0 | 24.0 | 11 | 6.0 | 44.0 | 4 | 4.4 | 16.0 | 2 | 6.9 | 8.0 | 2 | 5.9 | 8.0 | 25 | 4.7 | 100 | ||
Sex | Female | 86 | 43.2 | 38.7 | 78 | 42.9 | 35.1 | 35 | 38.5 | 15.8 | 9 | 31.0 | 4.1 | 14 | 41.2 | 6.3 | 222 | 41.5 | 100 | 0.729 |
Male | 113 | 56.8 | 36.1 | 104 | 57.1 | 33.2 | 56 | 61.5 | 17.9 | 20 | 69.0 | 6.4 | 20 | 58.8 | 6.4 | 313 | 58.5 | 100 | ||
Notification season | Autumn | 57 | 28.6 | 36.5 | 61 | 33.5 | 39.1 | 23 | 25.3 | 14.7 | 7 | 24.1 | 4.5 | 8 | 23.5 | 5.1 | 156 | 29.2 | 100 | 0.174 |
Spring | 47 | 23.6 | 33.8 | 46 | 25.3 | 33.1 | 31 | 34.1 | 22.3 | 8 | 27.6 | 5.8 | 7 | 20.6 | 5.0 | 139 | 26.0 | 100 | ||
Summer | 34 | 17.1 | 54.0 | 14 | 7.7 | 22.2 | 6 | 6.6 | 9.5 | 3 | 10.3 | 4.8 | 6 | 17.6 | 9.5 | 63 | 11.8 | 100 | ||
Winter | 61 | 30.7 | 34.5 | 61 | 33.5 | 34.5 | 31 | 34.1 | 17.5 | 11 | 37.9 | 6.2 | 13 | 38.2 | 7.3 | 177 | 33.1 | 100 | ||
Associated | Meningitis | 80 | 40.2 | 41.2 | 53 | 29.1 | 27.3 | 27 | 29.7 | 13.9 | 13 | 44.8 | 6.7 | 21 | 61.8 | 10.8 | 194 | 36.3 | 100 | <0.001 |
diseases | Sepsis | 138 | 69.3 | 45.1 | 90 | 49.5 | 29.4 | 52 | 57.1 | 17.0 | 11 | 37.9 | 3.6 | 15 | 44.1 | 4.9 | 306 | 57.2 | 100 | <0.001 |
Bacteremic pneumonia | 10 | 5.0 | 12.3 | 44 | 24.2 | 54.3 | 23 | 25.3 | 28.4 | 1 | 3.4 | 1.2 | 3 | 8.8 | 3.7 | 81 | 15.1 | 100 | <0.001 | |
Other | 11 | 5.5 | 31.4 | 13 | 7.1 | 37.1 | 6 | 6.6 | 17.1 | 4 | 13.8 | 11.4 | 1 | 2.9 | 2.9 | 35 | 6.5 | 100 | <0.001 | |
Material | Blood | 135 | 67.8 | 39.0 | 122 | 67.0 | 35.3 | 64 | 70.3 | 18.5 | 14 | 48.3 | 4.0 | 11 | 32.4 | 3.2 | 346 | 64.7 | 100 | <0.001 |
Liquor | 74 | 37.2 | 43.5 | 44 | 24.2 | 25.9 | 21 | 23.1 | 12.4 | 10 | 34.5 | 5.9 | 21 | 61.8 | 12.4 | 170 | 31.8 | 100 | 0.046 | |
Other | 1 | 0.5 | 14.3 | 3 | 1.6 | 42.9 | 3 | 3.3 | 42.9 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 7 | 1.3 | 100 | 0.38 | |
Sequelae | All types | 2 | 1.0 | 40.0 | 1 | 0.5 | 20.0 | 1 | 1.1 | 20.0 | 1 | 3.4 | 20.0 | 0 | 0.0 | 0.0 | 5 | 0.9 | 100 | 0.461 |
Audiological | 0 | 0.0 | 0.0 | 1 | 0.5 | 50.0 | 0 | 0.0 | 0.0 | 1 | 3.4 | 50.0 | 0 | 0.0 | 0.0 | 2 | 0.4 | 100 | 0.151 | |
Neurological | 1 | 0.5 | 100 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 1 | 0.2 | 100 | 1 | |
Other | 2 | 1.0 | 66.7 | 0 | 0.0 | 0.0 | 1 | 1.1 | 33.3 | 0 | 0.0 | 0.0 | 0 | 0.0 | 0.0 | 3 | 0.6 | 100 | 0.578 | |
Deceased | Yes | 6 | 9.4 | 25.0 | 10 | 18.2 | 41.7 | 3 | 12.5 | 12.5 | 3 | 20.0 | 12.5 | 2 | 15.4 | 8.3 | 24 | 14.0 | 100 | 0.603 |
NA | 135 | 127 | 67 | 14 | 21 | 364 | ||||||||||||||
Total | 199 | 100 | 37.2 | 182 | 100 | 34.0 | 91 | 100 | 17.0 | 29 | 100 | 5.4 | 34 | 100 | 6.4 | 535 | 100 | 100 |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Cocchio, S.; Cozzolino, C.; Cozza, A.; Furlan, P.; Frasson, E.; Tarantino, S.; Conte, E.; Chiusaroli, L.; Amoruso, I.; Zanella, F.; et al. Surveillance of Pediatric Invasive Bacterial Diseases in the Veneto Region: Epidemiological Trends and Outcomes over 17 Years (2007–2023). Vaccines 2025, 13, 230. https://doi.org/10.3390/vaccines13030230
Cocchio S, Cozzolino C, Cozza A, Furlan P, Frasson E, Tarantino S, Conte E, Chiusaroli L, Amoruso I, Zanella F, et al. Surveillance of Pediatric Invasive Bacterial Diseases in the Veneto Region: Epidemiological Trends and Outcomes over 17 Years (2007–2023). Vaccines. 2025; 13(3):230. https://doi.org/10.3390/vaccines13030230
Chicago/Turabian StyleCocchio, Silvia, Claudia Cozzolino, Andrea Cozza, Patrizia Furlan, Enrica Frasson, Sara Tarantino, Elisabetta Conte, Lorenzo Chiusaroli, Irene Amoruso, Francesca Zanella, and et al. 2025. "Surveillance of Pediatric Invasive Bacterial Diseases in the Veneto Region: Epidemiological Trends and Outcomes over 17 Years (2007–2023)" Vaccines 13, no. 3: 230. https://doi.org/10.3390/vaccines13030230
APA StyleCocchio, S., Cozzolino, C., Cozza, A., Furlan, P., Frasson, E., Tarantino, S., Conte, E., Chiusaroli, L., Amoruso, I., Zanella, F., Gentili, D., Tonon, M., Russo, F., Baldovin, T., & Baldo, V. (2025). Surveillance of Pediatric Invasive Bacterial Diseases in the Veneto Region: Epidemiological Trends and Outcomes over 17 Years (2007–2023). Vaccines, 13(3), 230. https://doi.org/10.3390/vaccines13030230